We are live on !
Find out more
KE
KLP Enterprises Portfolio holdings
AUM
$1.97M
This Fund
S&P 500
This Quarter Est. Return
-31.58%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17M
AUM Growth
-$7.83M
(-32%)
Cap. Flow
$0
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.5
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Celldex Therapeutics
CLDX
$2.43B
| $17M | 100% |
457,667
| – | – |
2016 Q4
2 quarters
|
|
Similar funds
NPAM
6C
KLP Enterprises's Q2 2017 Portfolio in Review
As of Q2 2017, KLP Enterprises held 1 position worth $17M, down 32% from $24.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2017: portfolio turnover was 0%. KLP Enterprises opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- KLP Enterprises's ten largest holdings make up 100% of its $17M portfolio in Q2 2017.
- KLP Enterprises opened 0 new positions and closed 0 in Q2 2017.
- KLP Enterprises's portfolio value fell 32% quarter-over-quarter to $17M.
Based on KLP Enterprises's 13F filing for Q2 2017, filed 10 Aug 2017.